Fact-checked by Grok 2 weeks ago

Thujone

Thujone is a monoterpene ketone with the molecular formula C₁₀H₁₆O, occurring naturally as two principal diastereomers, α-thujone and β-thujone, in essential oils derived from plants such as Artemisia absinthium (wormwood), Thuja species, and Salvia officinalis (sage). These compounds contribute to the flavor and aroma of certain herbal liqueurs, most notably absinthe, but thujone's notoriety stems from historical attributions of hallucinogenic and neurotoxic effects, which empirical analyses have largely refuted at concentrations found in such beverages. Structurally, thujone features a bicyclic monoterpenoid with a group, enabling its volatility and , including of γ-aminobutyric acid type A (GABA_A) receptors, which underlies its convulsant potential in elevated doses. Regulatory limits on thujone in foodstuffs reflect concerns over , yet toxicological studies indicate that safe exposure thresholds are rarely approached in culinary or moderate alcoholic contexts, with often responsible for observed intoxications misattributed to thujone. The compound's defining controversy arose in the late 19th and early 20th centuries amid bans, fueled by anecdotal reports of "absinthism" rather than rigorous , but gas chromatography-mass of vintage samples confirms thujone levels below 5 mg/L—insufficient for GABA disruption at consumed volumes. Modern syntheses and plant extractions highlight thujone's role in biopesticides and potential analogs, underscoring its pharmacological duality beyond outdated myths.

Chemical Properties

Molecular Structure and Isomers

Thujone is a bicyclic monoterpenoid with the molecular formula C₁₀H₁₆O, featuring a fused ring and a moiety, along with an isopropenyl . The core structure is based on a bicyclo[3.1.0] skeleton, where the group is positioned at carbon 3, contributing to its reactivity due to the proximity of the strained ring. Thujone occurs primarily as two diastereoisomers: α-thujone and β-thujone, which differ in the at the C4 position relative to the ketone-bearing carbon. The natural forms are predominantly (−)-α-thujone, with (1S,4R,5R) , and (+)-β-thujone, with (1S,5S) . Enantiomers such as (+)-α-thujone exist but are less common in natural sources. These isomers exhibit distinct three-dimensional arrangements due to the at multiple centers, including the fusion, which imparts specific spatial orientations to the methyl and isopropenyl groups. The from the ring influences the overall , as evidenced by spectroscopic data confirming the bicyclic framework.

Physical and Spectroscopic Characteristics

Thujone exists as a colorless to pale yellow viscous liquid at , with a below 25 °C. Its boiling point ranges from 200 to 202 °C at 760 mm . The is approximately 0.92–0.93 g/cm³ at 25 °C, and the is n²⁰_D ≈ 1.455. Thujone shows poor in water (<0.1 g/L) but dissolves readily in organic solvents such as ethanol, ether, and chloroform. Optical activity varies among its stereoisomers; for example, (+)-β-thujone exhibits a specific rotation [α]¹⁵_D of +72.5°. The enantiomers of α-thujone and β-thujone display opposing rotations, with natural occurrences often featuring (-)-α-thujone and (+)-β-thujone in plant-derived samples. Thujone's volatility contributes to its presence in the vapor phase of essential oils, though it remains relatively stable under ambient conditions, with potential for slow oxidation over time. Infrared (IR) spectroscopy identifies thujone by its strong carbonyl stretching band at 1710–1740 cm⁻¹, characteristic of the strained cyclopentanone moiety. Proton nuclear magnetic resonance (¹H NMR) reveals diagnostic signals, such as the CH₂ protons adjacent to the carbonyl at δ 2.11–2.13 ppm for , alongside methyl singlets or doublets near δ 0.8–1.0 ppm. In electron ionization mass spectrometry, thujone yields a molecular ion [M]⁺ at m/z 152, with notable fragments at m/z 137 (loss of CH₃), 124, 109, and 93 arising from ring cleavage and carbonyl-related cleavages. These patterns aid in distinguishing thujone from related monoterpenoids.

Natural Occurrence and Biosynthesis

Primary Plant Sources

Thujone occurs naturally as a monoterpene ketone in the essential oils of various plants, predominantly in species from the genera Artemisia, Tanacetum, and Salvia, as well as conifers like Thuja. These compounds are typically quantified via gas chromatography-mass spectrometry (GC-MS) analyses of distilled oils from aerial parts such as leaves and flowers. In Artemisia absinthium (wormwood), a member of the Asteraceae family, thujone levels in essential oil range widely but often include 3.2% α-thujone and up to 35% β-thujone, with total thujone content varying by chemotype and extraction method. Concentrations differ across plant organs and growth stages; for example, higher thujone yields have been observed in pre-flowering leaves compared to mature flowers in chromatographic studies of European cultivars. Similarly, Tanacetum vulgare (tansy), another Asteraceae species, can contain up to 82% β-thujone in its essential oil, particularly in inflorescences, though α-thujone may reach 44% in leaf rosettes during early development. Salvia officinalis (common sage, Lamiaceae) features thujone as a primary essential oil constituent, with total levels often exceeding 20% in leaves, subject to variation from environmental factors like soil nitrogen content and harvest timing. In coniferous sources, Thuja occidentalis (eastern white cedar, Cupressaceae) yields cis-thujone at 19.7–36.4% in leaf extracts across seasons, while Thuja plicata twig oils contain up to 65.9% (-)-α-thujone. Trace amounts appear in select Mentha species, but not as dominant components. Overall, thujone distribution reflects genotypic and abiotic influences, with higher concentrations generally in temperate-zone perennials analyzed via standardized hydrodistillation protocols.

Biosynthetic Pathways

Thujone biosynthesis follows the general monoterpenoid pathway in plant plastids, where dimethylallyl pyrophosphate (DMAPP) and isopentenyl pyrophosphate (IPP) are generated primarily via the methylerythritol phosphate (MEP) pathway, with potential contributions from the cytosolic mevalonate (MVA) pathway through inter-organelle exchange. These C5 units condense head-to-tail, catalyzed by geranyl pyrophosphate synthase (GPPS), to form the C10 precursor geranyl pyrophosphate (GPP). Transcriptomic profiling indicates that genes encoding MEP pathway enzymes, such as 1-deoxy-D-xylulose-5-phosphate synthase (DXS) and reductoisomerase (DXR), along with GPPS, exhibit elevated expression in tissues producing higher thujone levels, suggesting flux control at these early steps. GPP undergoes enzymatic cyclization to , mediated by (SS), a monoterpene synthase (TPS-b subfamily enzyme) that folds GPP into the bicyclic thujane skeleton via an initial isomerization to the α-terpinyl cation intermediate followed by 1,3-hydride shift and deprotonation. Isotope-labeling experiments using [10-³H]sabinene fed to leaf tissues demonstrate direct incorporation into 3-thujone and related C3-oxygenated derivatives, with dilution studies showing that exogenous , but not α-thujene, competitively inhibits endogenous thujone formation from labeled geraniol precursors, confirming sabinene's proximal role. Downstream conversion proceeds via allylic hydroxylation of sabinene to sabinol (primarily trans-sabin-3-ol), catalyzed by cytochrome P450 monooxygenases such as sabinene-2-hydroxylases (e.g., or members), followed by oxidation of sabinol to sabinone by NAD+-dependent dehydrogenases. Sabinone is then stereoselectively reduced to α-thujone or β-thujone by NADPH-dependent ketoreductases, with isomer specificity arising from enzyme active-site geometry that favors hydride delivery from one face of the carbonyl, as evidenced by in vitro assays with cloned reductases yielding enantiopure products. Functional expression of pathway genes from thujone-accumulating species has reconstructed these steps heterologously, producing thujone isomers in ratios mirroring natural profiles and highlighting stereochemical branching at the reduction stage. Candidate genes for these oxidoreductases, identified via comparative RNA-seq, show differential upregulation correlating with thujone yield, though full enzymatic cascades remain under characterization.

Pharmacological and Toxicological Profile

Mechanisms of Action

Thujone, particularly its α-isomer, acts as a noncompetitive antagonist at GABA_A receptors, binding to a site distinct from the GABA binding domain and thereby reducing chloride influx in a dose-dependent manner, which diminishes inhibitory neurotransmission and promotes neuronal excitation at concentrations exceeding 100 μM in recombinant expression systems. This antagonism exhibits subtype selectivity, with the strongest inhibition observed on extrasynaptic α1β2δ-containing GABA_A receptors implicated in tonic inhibition, compared to weaker effects on synaptic α1β2γ2 receptors mediating phasic inhibition, as evidenced by patch-clamp electrophysiology showing IC50 values around 50-200 μM depending on subunit composition. The mechanism parallels that of picrotoxin, involving channel pore blockade, but with lower potency, requiring higher doses for comparable pro-convulsant outcomes in rodent models where intraperitoneal administration of 20-50 mg/kg induces seizures via reduced GABAergic tone. α-Thujone also inhibits serotonin 5-HT3 receptors, reducing agonist-induced currents in patch-clamp studies on both homomeric (5-HT3A) and heteromeric (5-HT3AB) assemblies with an IC50 of approximately 50 μM, primarily by accelerating receptor desensitization rather than directly blocking the ion channel. This modulation occurs independently of GABA_A effects and may contribute to thujone's overall neuropharmacological profile, though its functional significance remains under investigation due to limited in vivo correlation data. Thujone undergoes phase I metabolism primarily via cytochrome P450 enzymes, including CYP2A6 and CYP3A4 in humans, yielding hydroxylated derivatives such as 7-hydroxy-α-thujone (major in mice, rats, and humans), 4-hydroxythujone, and 2-hydroxythujone, which exhibit reduced convulsant potency relative to the parent compound. In vitro human liver microsome incubations demonstrate rapid biotransformation with half-lives under 30 minutes, while rodent pharmacokinetic studies report plasma clearance within hours post-administration, facilitating detoxification through conjugation and urinary excretion.

Empirical Toxicity Data

Acute oral administration of α-thujone to rats yielded an LD50 of 500 mg/kg body weight, while β-thujone exhibited an LD50 of 250 mg/kg in mice, indicating α-thujone's greater potency in inducing neurotoxic effects such as convulsions at doses approaching lethality. Intraperitoneal LD50 values for α-thujone in mice were lower, at approximately 45 mg/kg, with 100% mortality observed at 60 mg/kg and associated with rapid onset of seizures. β-Thujone demonstrates reduced acute neurotoxicity compared to the α-isomer, as evidenced by higher subcutaneous LD50 thresholds in mice (greater than 87.5 mg/kg for α versus substantially higher for β). In subchronic and chronic studies, thujone exposure via gavage at doses exceeding 25 mg/kg/day resulted in behavioral alterations, , and weight reductions, including hepatic and renal changes, though no-observed-adverse-effect levels (NOAELs) were established around 11 mg/kg/day for repeated dosing in guideline-compliant assessments. The National Toxicology Program's 2-year gavage studies in rats and mice reported increased incidences of seizures and equivocal evidence of renal tubule adenomas in male F344/N rats at doses up to 30 mg/kg/day, but no clear renal toxicity threshold below 100 mg/kg/day was identified in lower-dose exposures. Genotoxicity evaluations of α- and β-thujone, including Salmonella/E. coli mutagenicity assays (Ames test), were negative both with and without metabolic activation, aligning with OECD guideline protocols. Carcinogenicity assays showed no consistent tumor induction across sexes and strains, though some equivocal renal findings in rats were noted without genotoxic support. Relative to other monoterpenes, thujone exhibits moderate , with LD50 values lower than camphor's (approximately 1,500 mg/kg oral in rats) but comparable to , emphasizing its pronounced neurotoxic profile over generalized in bacterial and mammalian cell assays. These metrics underscore thujone's threshold-based , amenable to dose extrapolation for in reviews spanning the late 20th to early 21st centuries.

Safety Assessments and Human Studies

Human pharmacokinetic data demonstrate low systemic exposure to thujone from typical dietary sources such as absinthe, where concentrations rarely exceed 10 mg/L in regulated products, including historical pre-ban variants averaging 25 mg/L but with a median below 5 mg/L. A 2018 clinical study involving volunteers consuming commercial absinthe detected trace urinary α-thujone (peak ~0.1-0.5 µg/mL) and its less toxic hydroxy metabolites, which were rapidly excreted within 24 hours, indicating efficient hepatic metabolism via cytochrome P450-mediated hydroxylation and conjugation, with peak blood levels estimated below 1 µM—far under neuroactive thresholds derived from in vitro GABAA receptor modulation studies. Pharmacokinetic modeling corroborates that absorption from alcoholic beverages is limited by thujone's volatility and poor aqueous solubility, resulting in negligible plasma accumulation even with repeated moderate intake. Reviews of historical and contemporary data refute a distinct "absinthism" syndrome causally linked to thujone, attributing reported hallucinations, seizures, and neuropathy to toxicity and nutritional deficiencies in chronic abusers. A comprehensive analysis of 19th-century case reports found symptoms indistinguishable from alcoholic psychoses, with thujone doses (estimated <5 mg per serving) insufficient to elicit GABAergic antagonism at convulsant levels (>100 mg/kg in sensitive models). Subsequent meta-reviews (2006-2020) across epidemiological cohorts of herbal users and consumers confirm no unique thujone-associated , as adverse events correlate solely with overdose from essential oils (>1 g pure thujone) rather than food-grade exposures. Acceptable daily intake estimates range from 3-7 mg for adults, encompassing α- and β-thujone isomers, as endorsed by regulatory assessments balancing conservative animal-derived margins (e.g., NOAEL 25 mg/kg bw/day in ) with human absence of dose-related effects in supplement users. The sets herbal monograph limits at 3 mg/day for and 5 mg/day for , thresholds unmet even by high-volume , supported by showing no intoxications from compliant products since regulatory in 1988. A 2012 placebo-controlled trial further evidenced no differential mood or cognitive impairments from thujone-containing versus ethanol-equivalent controls, reinforcing safety at realistic doses.

Historical and Cultural Significance

Traditional Medicinal Uses

In folk medicine, (), a primary source of thujone, was employed as a vermifuge to treat intestinal helminth infections, with decoctions or infusions administered to expel parasites such as roundworms and tapeworms. This practice, documented from ancient Egyptian records where served as an additive to wine for parasitic relief, persisted through the as a purge for worm infestations, often prepared by boiling 1-2 grams of dried herb in water for oral consumption. Ethnopharmacological accounts attribute efficacy to thujone's bitter principles stimulating digestion and motility, though empirical success likely stemmed from the plant's overall lactones rather than isolated thujone; assays confirm effects against nematodes like , paralyzing larvae at concentrations of 2-5 mg/mL, aligning with historical observations without implying causation in human cases. Salvia officinalis (sage), containing 15-45 mg/g thujone in its essential oil, featured in pre-20th-century European traditions for anti-inflammatory throat remedies, including gargles or teas for infections and hoarseness, as noted in ancient Greek texts by Dioscorides for soothing coughs and ulcers. Preparations involved infusing 1-2 grams of leaves in hot water, yielding mild astringent and antimicrobial actions against oral pathogens; thujone contributes via disrupting bacterial membranes, with essential oil extracts inhibiting Staphylococcus aureus growth at minimum inhibitory concentrations of 0.5-1% v/v in laboratory tests, corroborating anecdotal relief from streptococcal or staphylococcal tonsillitis without endorsing unverified curative claims. Native American ethnopharmacological records sparingly reference thujone-rich Artemisia species, such as A. ludoviciana, for digestive tonics and washes in Plains tribes, prepared as cold infusions for gastrointestinal ailments, though documentation relies on 19th-century ethnobotanical surveys rather than direct pre-colonial verification, distinguishing these from broader vermifuge . Overall, traditional applications emphasized low-dose preparations to mitigate toxicity risks, prioritizing empirical symptom alleviation over mechanistic understanding.

Role in Absinthe Production

Thujone enters during the maceration of (grand ) leaves and flowering tops in neutral , typically alongside and , prior to in traditional 19th-century methods. An 1855 recipe from , , specifies macerating 2.5 kilograms of dried with other botanicals in for several days before to essential oils, including thujone, which imparts herbaceous and slightly camphoraceous notes to the spirit's profile. This process yields incomplete , with via steam-water methods recovering approximately 80% of thujone from the macerate while separating it from more polar bitters like absinthin. In the final product, thujone synergizes with dominant volatiles such as from (providing licorice-like sweetness) and fenchone from (adding minty sharpness), contributing to 's layered bitter-earthiness without dominating the anise-forward bouquet. Gas chromatography-mass spectrometry (GC-MS) analyses of vintage pre-ban samples confirm thujone concentrations typically ranging from 0.5 to 48.3 mg/L, with an average of 25.4 ± 20.3 mg/L across tested artifacts. These levels reflect variable quality and efficiency in historical batches, as higher yields occur with prolonged cold maceration but traditional hot tempers to balance flavor intensity.

Myths, Controversies, and Scientific Debunking

The myth of thujone as a potent , often linked to absinthe's nickname "Green Fairy," arose from 19th-century anecdotal accounts among bohemian artists and writers who attributed vivid visions and altered states to the , rather than its high content of 45-75% ABV. These claims gained traction amid sensationalized literature and press, but empirical analysis reveals thujone concentrations in historical pre-ban absinthes averaged 25.4 mg/L (range 0.5-48.3 mg/L), levels insufficient to disrupt GABA_A receptors at psychoactive doses, which require hundreds of milligrams per kilogram body weight in animal models. A 2008 review confirmed that even peak historical exposures fell short of thresholds for neuroexcitation or hallucinations, attributing perceived effects to ethanol's potentiation of and . The purported syndrome "absinthism"—characterized by hallucinations, , and mental deterioration—was described in 19th-century as uniquely tied to , yet a toxicological examination classified it as fictitious, with symptoms mirroring chronic from any high-proof spirit, absent distinguishing thujone markers in autopsies or case series. No epidemiological evidence supports thujone-linked epileptic outbreaks; isolated convulsions reported pre-ban aligned with alcohol withdrawal or contaminants like from adulterated copper boilers, not wormwood-derived thujone. Modern rodent studies show thujone's convulsant potential only at supraphysiological doses (e.g., 100 mg/kg intraperitoneally), far exceeding absinthe ingestion equivalents. Absinthe prohibitions, such as Switzerland's 1908 ban and the U.S. Pure Food and Drug Act extension in 1915, stemmed primarily from temperance campaigns portraying the emerald liquor as a societal scourge amid rising alcoholism fears, compounded by verified adulteration scandals (e.g., toxic metals in cheap distillates) rather than verified thujone perils. Pre-ban thujone yields mirrored contemporary formulations using similar wormwood distillates, undermining toxicity as the causal driver; bans reflected moral panics equating absinthe's cultural allure with deviance, not causal data on its principal bitter. Persistent media portrayals, from Van Gogh lore to film tropes, perpetuate these unsubstantiated links despite refutations, often prioritizing narrative over assays showing thujone's stability and low bioavailability in alcoholic matrices.

Regulatory Framework

European Union Standards

In the , thujone content in foodstuffs is regulated under Regulation (EC) No 1334/2008 on flavourings and Annex III thereof, which establishes maximum levels to ensure consumer safety while permitting indirect presence from natural sources such as and . For alcoholic beverages exceeding 25% (ABV), the limit is set at 35 mg/L of β-thujone; for those at or below 25% ABV, it is 5 mg/L; and for non-alcoholic foods containing Artemisia species (excluding sage), it is 0.5 mg/kg. These thresholds, derived from the 2002 Scientific Committee on Food (SCF) opinion, incorporate precautionary margins from animal toxicity data, including a no-observed-effect level () of 5 mg/kg body weight per day for convulsions in female rats, extrapolated with safety factors exceeding 100-fold for humans. The (EFSA), succeeding the SCF, has reaffirmed the low risk of thujone at these levels through flavouring evaluations, with no substantive regulatory updates since the 2010s, indicating stability amid ongoing assessments of essential oils and herbal derivatives. Empirical data, including subchronic rodent studies showing neurotoxic effects only at doses far above typical exposures (e.g., >10 mg/kg bw), suggest these limits embed margins substantially larger than required, as proposed ADIs of 0.11 mg/kg bw/day remain unapproached even in high-consumption scenarios like multiple servings of thujone-containing teas or absinthes. Joint FAO/WHO Expert Committee on Food Additives (JECFA) evaluations similarly allocate no numerical ADI, deeming incidental levels from flavourings safe without restriction. For herbal medicinal products, the () enforces stricter daily intake limits under Directive 2004/24/EC, capping thujone at 6 mg/day for adults in short-term preparations and 5 mg/day for , with lower thresholds for children and pregnant women to account for vulnerable populations. Compliance is verified through analytical testing of raw materials and finished products, often via gas chromatography-mass spectrometry, with member states responsible for enforcement under general food law (Regulation (EC) No 178/2002). While these variations prioritize caution for therapeutic contexts, toxicity profiles indicate over-regulation relative to human data, where adverse effects require acute overdoses (e.g., >30 mg/kg in case reports), underscoring precautionary approaches beyond empirical necessities.

United States Restrictions

The U.S. (FDA) prohibits thujone as a direct under 21 CFR 172.510, which restricts the use of certain flavoring substances containing thujone, such as extracts from (), due to concerns over potential . This regulation deems thujone unsafe for addition to food or beverages, requiring alcoholic products to be effectively thujone-free. The prohibition traces to a 1912 ban on imports, enacted via Food Inspection Decision 147 under the of 1906, which targeted absinthe as adulterated owing to its thujone content amid moral panics over "absinthism"—a later questioned for lack of causal evidence linking low-dose thujone to hallucinations or convulsions. This measure persisted through the without revision based on subsequent studies, maintaining import restrictions despite evolving scientific understanding that historical fears exaggerated risks at typical exposure levels. In 2007, the Alcohol and Tobacco Tax and Trade Bureau (TTB) permitted domestic production and importation of absinthe labeled as thujone-free, defining this threshold as less than 10 parts per million (ppm) via laboratory testing protocols, including gas chromatography-mass spectrometry for compliance verification. Importers must submit product samples to TTB for thujone analysis prior to approval, enforcing the limit to align with FDA standards. Exemptions apply to essential oils with negligible thujone content, classified as (GRAS) under 21 CFR 182.20 when used in non-food applications or diluted forms meeting good manufacturing practices, allowing limited import and use in flavors or absent detectable thujone. These provisions reflect a regulatory persistence rooted in early 20th-century precautionary assumptions rather than reassessments incorporating modern pharmacokinetic indicating minimal acute risk below certain thresholds.

Canadian and Other International Regulations

Health Canada regulates thujone primarily through the Canadian Food Inspection Agency (CFIA), which enforces limits in foods and beverages containing thujone-bearing plants like Artemisia absinthium, aligning with the U.S. standard of less than 10 parts per million (ppm) for absinthe and similar products to mitigate potential neurotoxic risks. This threshold applies to commercial absinthe sales across provinces such as Ontario, Alberta, and Nova Scotia, where thujone content is capped at approximately 10 milligrams per kilogram, with no documented revisions to these limits between 2023 and 2025. Health Canada advises moderation, noting a daily intake ceiling of around 6 milligrams to avoid adverse effects, though empirical data suggest lower risks at typical exposure levels from regulated products. Internationally, regulatory approaches vary, often diverging from North American stringency despite aligned toxicological profiles indicating low hazard at trace levels. In , Food Standards Australia New Zealand (FSANZ) permits thujone in flavoring agents from plants like (Artemisia dracunculus) without absolute prohibition, but imposes maximum residue limits for wormwood-derived products in line with thresholds—up to 35 milligrams per liter in certain bitter liqueurs—while historically requiring import permits for high-thujone to ensure compliance. allows thujone-containing herbal plants in foods without blanket restrictions on natural extracts, though stricter controls apply to isolated compounds or concentrated teas, prioritizing additive purity under the Food Sanitation Act to limit potential cumulative exposure in daily consumption. In emerging markets like , thujone faces no specific quantitative caps in traditional Ayurvedic or formulations, where and species are incorporated for medicinal uses under the oversight, emphasizing historical safety over empirical potency limits absent from the Drugs and Cosmetics Act amendments as of 2023. This permissiveness contrasts with precautionary models elsewhere, underscoring global inconsistencies: while Joint FAO/WHO Expert Committee on Food Additives (JECFA) evaluations affirm that thujone levels from approved flavorings pose no appreciable health concern, adoption varies, with some jurisdictions prioritizing cultural precedents over uniform risk-based harmonization.

Synthesis and Modern Applications

Chemical Synthesis Methods

Thujone, particularly α-thujone, has been synthesized via concise routes emphasizing stereocontrol and efficiency. A three-step enantioselective method starts from commercially available 3-methyl-1-butyne and enables access to either (+)- or (−)-α-thujone. The sequence begins with a Brown crotylation to establish initial enantioselectivity, followed by a gold(I)-catalyzed cycloisomerization that transfers to the carbon center with high fidelity. The final step completes the formation without requiring protecting groups, adjustments, or lengthy manipulations, rendering the process atom-economical and suitable for preparing pure enantiomers. An alternative six-step total synthesis originates from cyclopentadiene and acetone to form dimethylfulvene as the key intermediate. This is reduced to the corresponding cyclopentadiene, then subjected to hydroboration-oxidation yielding a cyclopentenol in 34% over three steps. Cyclopropanation employs the Furukawa-modified Simmons-Smith reaction to install the strained ring, followed by IBX oxidation of the alcohol to the ketone (77% yield). Regio- and diastereoselective methylation at C4 using potassium bis(trimethylsilyl)amide and methyl iodide in N,N'-dimethylpropyleneurea affords α-thujone in 75% yield, with the method adaptable for d6-labeled variants via deuterated acetone for isotopic studies. These routes address stereocontrol challenges inherent to thujone's bicyclic structure, where the fusion demands precise diastereoselectivity; earlier methods often struggled with low yields or . Purification typically involves to isolate products at >95% purity, as intermediates are purified similarly to remove byproducts. While direct chemical oxidations from analogs exist in biosynthetic mimicry, total syntheses provide greater flexibility for isomer-specific production over partial routes prone to side reactions.

Industrial and Therapeutic Uses

Thujone-containing essential oils, derived from plants such as and , are employed in flavoring non-alcoholic products like herbal liqueurs and , where concentrations are strictly regulated to below 5 ppm in approved essences to ensure safety. These oils contribute aromatic profiles reminiscent of and mint, enhancing sensory qualities in formulations compliant with standards that cap total thujone at 0.5–6 mg/kg in foodstuffs depending on the matrix. In perfumery and , α-thujone serves as a volatile fragrance agent, imparting thujonic, woody notes in compositions, often sourced from cedarwood or essential oils, though synthetic alternatives are increasingly preferred to circumvent regulatory concerns. Essential oils rich in thujone exhibit antimicrobial activity against gram-positive and , as well as fungi, attributed to membrane disruption by the compound's structure, positioning them as potential preservatives in industrial applications pending further regulatory approval. Similarly, thujone demonstrates insecticidal and repellent effects in lab assays against pests like (Myzus persicae) and lesser mealworm larvae (), with α-thujone showing via neurotoxic mechanisms, though practical deployment faces hurdles from mammalian safety limits and environmental persistence requirements. Preclinical investigations highlight α-thujone's potential anti-cancer effects, particularly in multiforme (GBM) models, where concentrations of 100–500 μg/mL reduced cell viability, proliferation, and invasion while promoting and inhibiting via downregulation of VEGF and markers. In vitro and rat studies from 2016–2020 confirmed cytostatic actions and immune response stimulation against GBM, yet no clinical trials advancing to human phases were reported by 2025, underscoring the gap between promising lab data and validated therapeutic use.

References

  1. [1]
    Thujone | C10H16O | CID 261491 - PubChem - NIH
    Primary Hazards. Acute Toxic. Irritant. Laboratory Chemical Safety Summary (LCSS) Datasheet ; Molecular Formula. C10H16O ; Synonyms. alpha-Thujone; 546-80-5; (-)- ...
  2. [2]
    beta-Thujone | C10H16O | CID 91456 - PubChem
    Primary Hazards. Irritant. Laboratory Chemical Safety Summary (LCSS) Datasheet ; Molecular Formula. C10H16O ; Synonyms. beta-Thujone ; Molecular Weight. 152.23 g/ ...
  3. [3]
    Thujone - an overview | ScienceDirect Topics
    Thujone occurs naturally in two diastereomeric forms: (−)-α-thujone and (+)-β-thujone (Fig. 14.3). In regards to health effects, the existence of α-thujone or β ...
  4. [4]
    Chemical Composition of Vintage Preban Absinthe with Special ...
    The claims of high thujone concentrations up to 260 mg/L are now clearly disproven by the results of this study.Thujone · Fenchone And Pinocamphone · Methanol And Higher Alcohols
  5. [5]
    Thujone-attributable effects of absinthe are only an urban leg-end
    Aug 7, 2025 · ... thujone content of absinthe may have been verified by a number of independent studies. Based on the current available evidence, thujone ...
  6. [6]
    α-Thujone (the active component of absinthe): γ-Aminobutyric acid ...
    α-Thujone is the toxic agent in absinthe, a liqueur popular in the 19th and early 20th centuries that has adverse health effects.
  7. [7]
    [PDF] a-Thujone - National Toxicology Program
    Structure Activity Relationships: The unsymmetric bicyclic ring structure of thujone is characteristic of a group of natural products found widely in spices and ...Missing: sources | Show results with:sources
  8. [8]
    Toxicity of Selected Monoterpenes and Essential Oils Rich in These ...
    Mar 6, 2022 · Thujone was revealed as having the highest neurotoxic activity within the plant and is considered as being responsible for its neurotoxic ...
  9. [9]
    Absinthe—is its history relevant for current public health?
    Thujone has a blocking effect on GABAA neurotransmitter receptors in the central nervous system, which are involved in decreasing anxiety (in contrast to ...Absinthe--Is Its History... · Absinthe--Its History And... · Absinthe Today
  10. [10]
    Thujone concentration in pre-ban absinthe - The BMJ
    Dec 18, 1999 · Absinthes produced according to historic recipes only contained relatively low concentrations of thujone (mean: 1.3 ± 1.6 mg/l, range: 0 - 4.3 mg/l).
  11. [11]
    Thujone, a widely debated volatile compound: What do we know ...
    Apr 16, 2020 · Thujone is a volatile monoterpene ketone of plant origin which is produced by several plants that are frequently used for flavoring foods and beverages.
  12. [12]
    attention performance and mood under the influence of thujone
    Objective: The aim of this study was to determine whether the impacts of absinthe on attention performance and mood were different from those experienced ...Missing: empirical studies
  13. [13]
  14. [14]
    Beta Thuyone - an overview | ScienceDirect Topics
    β-Thujone is defined as a bicyclic ketone with the chemical formula C₁₀H₁₆O, recognized as one of the stereoisomers of thujone, specifically noted for its 1S,4 ...
  15. [15]
    alpha, beta-Thujone | C10H16O | CID 10931629 - PubChem
    Results: Thujone is characterized by m/z fragments of 81, 95, 110, and 152, with differing ratios for the alpha and beta isomers. Total thujone content ranged ...
  16. [16]
    β-Thujone and Its Derivatives Modify the Probing Behavior of ... - MDPI
    May 14, 2019 · Thujone is a bicyclic monoterpene ketone that occurs naturally in two diastereoisomeric forms, (−)-α-thujone (1) and (+)-β-thujone (2), that ...<|separator|>
  17. [17]
    Buy alpha,beta-Thujone | 76231-76-0 - Smolecule
    Rating 5.0 (1) Molecular Formula and Weight. Alpha,beta-thujone is a ketone and monoterpene compound with the molecular formula carbon ten hydrogen sixteen oxygen (C₁₀H₁₆O) ...
  18. [18]
  19. [19]
    [PDF] Safety Data Sheet: α,β-Thujone (isomers) - Carl ROTH
    Mar 3, 2024 · Melting point/freezing point not determined. Boiling point or initial boiling point and boiling range. 200 – 202 °C. Flammability this material ...
  20. [20]
    Thujone - chemeurope.com
    Thujone ; Density, 0.92 g/cm³ ; Solubility, insoluble (water) soluble (ethanol) ; Melting point, xx.x °C ; Boiling point, 201 °C.Missing: physical | Show results with:physical
  21. [21]
    THUJONE CAS#: 471-15-8 - ChemicalBook
    Melting point, 170 °C. alpha, D15 +72.5°. Boiling point, 84-86 °C17 mm Hg(lit.) Density, 0.925 g/mL at 25 °C(lit.) refractive index, n 20/D 1.455(lit.).Missing: physical | Show results with:physical
  22. [22]
    [PDF] A three-step enantioselective synthesis of (+)- and (-)-α- thujone
    Aug 23, 2021 · The stereocontrolled three-step synthesis of either enantiomer of α-thujone from commercially available 3-methyl-1-butyne is described.
  23. [23]
    Infrared Spectrometry - MSU chemistry
    For simple aldehydes and ketones the stretching vibration of the carbonyl group gives rise to a strong and distinctive infrared absorption at 1710 to 1740 cm-1.Missing: thujone | Show results with:thujone
  24. [24]
    Rapid Determination of Total Thujone in Absinthe Using 1 H NMR ...
    Sep 22, 2011 · In this article 1H NMR spectroscopy was applied for the analysis of total thujone content (sum of α- and β-thujone) in absinthes. We can ...
  25. [25]
    Chemical structure of α-thujone (the marked CH2 group is leading to ...
    Chemical structure of α-thujone (the marked CH2 group is leading to the 1H NMR shift at 2.13–2.11 ppm range, which is used for quantification). Source ...
  26. [26]
    Thujone - the NIST WebBook
    Thujone. Formula: C10H16O; Molecular weight: 152.2334. IUPAC Standard InChI: InChI=1S/C10H16O/c1-6(2)10-4-8(10)7(3)9(11)5-10/h6-8H,4-5H2,1-3H3/t7-,8-,10+/m1/s1
  27. [27]
    (PDF) Fragmentation and Reaction Rate Constants of Terpenoids ...
    Aug 10, 2025 · A monoterpene ketone, thujone, has been found to produce a fragment ion, m/z 93. Since the m/z 69 and 93 ions are the protonated molecular ions ...
  28. [28]
    Determination of the biologically active flavour substances thujone ...
    Jul 21, 2011 · The sage plant Salvia officinalis L. is used as ingredient in foods and beverages as well as in herbal medicinal products.
  29. [29]
    [PDF] Variability of thujone content in essential oil due to plant ...
    Mar 4, 2019 · In tansy (Tanacetum vulgaris), the maxi- mum proportion of α-thujone (44%) was detected in two stages: in the leaf rosette phase and at the ...
  30. [30]
    [PDF] Seasonality Study of Extracts from Leaves of Thuja occidentalis L.
    extract composition: cis-thujone, trans-thujone and trans-ferruginol. The content of cis-thujone varies between 19.7% in summer and 36.4% in spring, trans ...<|control11|><|separator|>
  31. [31]
    Thuja occidentalis L. (Cupressaceae): Ethnobotany, Phytochemistry ...
    Nov 19, 2020 · Thujone is the monoterpene found in the composition of many plants including Thuja occidentalis. However, the use of this compound is regulated ...
  32. [32]
    Comparative Transcriptome Analysis of High and Low Thujone ...
    Feb 9, 2023 · In this study, we identify candidate genes involved in the synthesis and regulation of thujone content in A. argyi leaves by the comparative transcriptome ...
  33. [33]
  34. [34]
    Sabinene in Thujone Biosynthesis in Western Redcedar | Plant ...
    Thujones are produced from (+)-sabinene by sabinol and sabinone. Using metabolite analysis, enzyme assays with WRC tissue extracts, cloning, and functional ...
  35. [35]
    sabinene in Thujone Biosynthesis in Western Redcedar - PubMed
    Thujones are produced from (+)-sabinene by sabinol and sabinone. Using metabolite analysis, enzyme assays with WRC tissue extracts, cloning, and functional ...
  36. [36]
    Monoterpene α-thujone exerts a differential inhibitory action on ...
    Feb 28, 2013 · Monoterpene α-thujone exerts a differential inhibitory action on GABA(A) receptors implicated in phasic and tonic GABAergic inhibition.
  37. [37]
    Monoterpene α-thujone exerts a differential inhibitory action on ...
    We report that α-thujone inhibits all considered receptor types by a qualitatively similar mechanism but the strongest effect is observed for α1β2δ receptors, ...Missing: mechanism | Show results with:mechanism
  38. [38]
    Alpha-thujone (the active component of absinthe) - PubMed - NIH
    Four observations establish that alpha-thujone is a modulator of the gamma-aminobutyric acid (GABA) type A receptor.Missing: action | Show results with:action
  39. [39]
    Thujone and thujone-containing herbal medicinal and botanical ...
    Thujone, a major component of the notoriously famous absinthe drink, is neurotoxic, although the current view rather downgrades its risk to humans.Missing: synthase | Show results with:synthase
  40. [40]
    Alpha-thujone reduces 5-HT3 receptor activity by an effect ... - PubMed
    In the present study, patch-clamp experiments revealed an inhibitory action of alpha-thujone on both homomeric and heteromeric 5-HT3 receptors. This inhibitory ...
  41. [41]
    α-Thujone reduces 5-HT3 receptor activity by an effect on the ...
    In animal studies, thujone inhibits the gamma-aminobutyric acid A (GABAA) receptor causing excitation and convulsions in a dose-dependent manner, although ...
  42. [42]
    Metabolism of α-thujone in human hepatic preparations in vitro
    This study aims to characterize the metabolism of α-thujone in human liver preparations in vitro and to identify the role of cytochrome P450 (CYP) and possibly ...
  43. [43]
    Detoxification of alpha- and beta-Thujones (the active ingredients of ...
    Our earlier study established that they are convulsants and have insecticidal activity, acting as noncompetitive blockers of the gamma-aminobutyric acid (GABA) ...Missing: mechanism action<|separator|>
  44. [44]
    Quantification of α-Thujone and Its Metabolites in Human Urine after ...
    Dec 3, 2018 · After consumption of a sage infusion, the α-thujone metabolites 2-hydroxythujone, 4-hydroxythujone, and 7-hydroxythujone were quantified in urine.
  45. [45]
    (PDF) Metabolism of α-thujone in human hepatic preparations in vitro
    PDF | This study aims to characterize the metabolism of α-thujone in human liver preparations in vitro and to identify the role of cytochrome P450 (CYP).
  46. [46]
    [PDF] NTP TR 570 - National Toxicology Program
    Nov 11, 2011 · The genetic toxicity of α-thujone and α,β-thujone was assessed by ... molecular structure of the chemical and its observed effects in ...
  47. [47]
    [PDF] RIFM fragrance ingredient safety assessment, bicyclo[3.1.0]hexan-3 ...
    Aug 14, 2019 · Under the conditions of the study, α-thujone was not mutagenic in the Ames test. The clastogenic activity of additional material α-thujone ...
  48. [48]
    Abstract for TR-570 - National Toxicology Program - NIH
    May 19, 2025 · Under the conditions of these 2-year gavage studies, there was some evidence of carcinogenic activity of α,β-thujone in male F344/N rats based ...
  49. [49]
    Toxicology and carcinogenesis studies of alpha,beta-thujone (CAS ...
    We studied the effects of α,β-thujone on male and female rats and mice to identify potential toxic or cancer-related hazards.
  50. [50]
    [PDF] Public statement on the use of herbal medicinal products containing ...
    Jan 27, 2011 · In in vitro liver microsomal incubations with α-thujone, 7-hydroxy-α-thujone seems to be a major metabolite in mice, rats and humans, whereas ...
  51. [51]
    Genetic Toxicity Evaluation of alpha-Thujone in Salmonella/E.coli ...
    Genetic Toxicity Evaluation of alpha-Thujone in Salmonella/E.coli Mutagenicity Test or Ames Test. Study A37723. Genetic Toxicology. Summary Data.
  52. [52]
    Comparative study of genotoxic, antigenotoxic and cytotoxic ...
    Dec 5, 2015 · Comparative study of genotoxic, antigenotoxic and cytotoxic activities of monoterpenes camphor, eucalyptol and thujone in bacteria and mammalian ...
  53. [53]
    Quantification of α-Thujone and Its Metabolites in Human Urine after ...
    Dec 3, 2018 · Therefore, the aim of the present study was to characterize the metabolism of α-thujone in humans in vivo by stable isotope dilution assays ( ...
  54. [54]
    [PDF] Opinion of the Scientific Committee on Food on Thujone
    Dec 2, 2002 · Thujone is reported to have antinociceptive activity in mice (Rice & Wilson, 1976) and the a- isomer is more potent and toxic than the b-isomer.
  55. [55]
    Absinthism: a fictitious 19th century syndrome with present impact
    Based on the current available evidence, thujone concentrations of both pre-ban and modern absinthes may not have been able to cause detrimental health effects ...
  56. [56]
    Thujone—Cause of absinthism? - ScienceDirect.com
    Apr 20, 2006 · Habitual abuse of the wormwood spirit absinthe was described in the 19th and 20th centuries as a cause for the mental disorder “absinthism”
  57. [57]
    Attention performance and mood under the influence of thujone
    Aug 10, 2025 · The aim of this study was to determine whether the impacts of absinthe on attention performance and mood were different from those ...
  58. [58]
    Wormwood – Health Information Library | PeaceHealth
    As a traditional medicine, wormwood was used by herbalists as a bitter to improve digestion, to fight worm infestations, and to stimulate menstruation.
  59. [59]
    Wormwood: The Parasite-Killing, Cancer-Fighting Super Herb
    Aug 30, 2024 · In ancient Egyptian times, it was a commonly used medicinal plant, specifically for anal pain, and as an additive to wine. Later on it was used ...
  60. [60]
    Anthelmintic Activity of Wormwood (Artemisia absinthium L.) and ...
    The objective of this study is to evaluate the effect of dry wormwood and mallow on the gastrointestinal parasite of small ruminants Haemonchus contortus.
  61. [61]
    Sage | Herbs - Herbal Reality
    Feb 23, 2023 · In Ancient Greece sage was used to staunch bleeding of wounds and to clean ulcers and sores, to soothe hoarseness and coughs, to enhance memory ...
  62. [62]
    Antibacterial Activity of Ethyl Acetate Extract of Platycladus orientalis ...
    The extract showed remarkable antibacterial activity against Staphylococcus saprophyticus, the disc diffusion test recorded 16.0±1.0mm zone of inhibition, with ...
  63. [63]
    Native American Ethnobotany Database: BRIT
    A database of foods, drugs, dyes and fibers of Native American peoples, derived from plants. Search the database
  64. [64]
    Wormwood (Artemisia absinthium L.)—A curious plant with both ...
    Aug 19, 2010 · In the Middle Ages, wormwood was used as a purge and vermifuge, and it developed towards a “general remedy for all diseases” and was referred to ...Letter To The Editor · Abstract · Introduction
  65. [65]
    Absinthe Terms | Scientific American
    Dec 10, 2007 · An 1855 recipe from Pontarlier, France, gives the following Instructions for making absinthe: Macerate 2.5 kilograms of dried wormwood, 5 ...
  66. [66]
    How to make Absinthe the right way - Alandia.de
    Nov 2, 2016 · Real Absinthe uses wormwood, anise, and fennel, distilled with wine alcohol, and colored with herbs. Maceration is not considered real Absinthe.
  67. [67]
    Behaviour of thujone during distillation and possible concentration ...
    Jul 10, 2007 · A discrepancy in the magnitude of thujone concentrations in distilled pre-ban absinthe has existed until now. Concentrations of 260 mg L−1 ...
  68. [68]
    [PDF] Absinthe: how history influences scientific inquiry
    Oct 5, 2025 · complete extraction of thujone from the wormwood during the maceration and colouring stages without distillation. Lachenmeier and Kuballa ...
  69. [69]
    Absinthe Myths Finally Laid To Rest - C&EN
    May 5, 2008 · In some reports, the thujone concentrations of absinthe were put as high as 350 mg/L, which is still not enough to cause toxic effects, Emmert ...Missing: pharmacokinetics | Show results with:pharmacokinetics<|separator|>
  70. [70]
    The Trouble with Absinthe - JSTOR Daily
    Jul 6, 2019 · When temperance advocates won the ban on absinthe in 1915, many of them saw it as the first step in a broader anti-drinking campaign.
  71. [71]
    Scientific Opinion on Flavouring Group Evaluation 06, Revision 4 ...
    Feb 20, 2013 · The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety Authority was requested to ...
  72. [72]
    Risk assessment of thujone in foods and medicines containing sage ...
    Although the assessors judged the toxicological data on thujone and the quality of available studies ... There is some equivocal evidence of carcinogenicity ...
  73. [73]
    thujone - WHO | JECFA
    ADI: NO ADI ALLOCATED. Comments: The Committee considered that the amounts of thujone isomers in foods and beverages resulting from the addition of thujone ...
  74. [74]
    21 CFR 172.510 -- Natural flavoring substances and natural ... - eCFR
    § 172.510 Natural flavoring substances and natural substances used in conjunction with flavors. ; Cedar, white (aborvitae), leaves and twigs, Thuja occidentalis ...
  75. [75]
    Screening of Distilled Spirits for Thujone by Gas Chromatography ...
    Jan 19, 2020 · Thujone is a monoterpenoid ketone consisting of two isomers, alpha and beta, that exist in varying ratios in different plants.
  76. [76]
    The Devil in a Little Green Bottle: A History of Absinthe
    Oct 5, 2010 · Absinthe went on trial in the court of public opinion, facing a newly hostile citizenry, its longtime enemies in the temperance movements, and ...
  77. [77]
    Industry Circular: 07-05 - Alcohol and Tobacco Tax and Trade Bureau
    Oct 16, 2007 · This circular explains the Alcohol and Tobacco Tax and Trade Bureau's (TTB) policy regarding the use of the term "absinthe" on labels of distilled spirits ...Missing: 182.20 | Show results with:182.20
  78. [78]
    21 CFR 182.20 -- Essential oils, oleoresins (solvent-free ... - eCFR
    Essential oils, oleoresins (solvent-free), and natural extractives (including distillates) that are generally recognized as safe for their intended use.Missing: thujone | Show results with:thujone
  79. [79]
    Absinthe now available at P.E.I. distillery for adventurous drinkers
    Jan 7, 2016 · The CFIA limits the amount of thujone allowed in each batch, and Health Canada warns drinkers not to consume more than six milligrams of ...
  80. [80]
    Absinthe Laws in Your Country
    The provinces of Ontario, Alberta, and Nova Scotia allow the sale of absinthe with a thujone content of about 10 milligrams per kilogram.Missing: Japan | Show results with:Japan
  81. [81]
    [PDF] Volume 2, Schedules 1 to 30 - Food Standards Australia New Zealand
    ... wormwood. Thujone, santonin. Artemisia cina Berg. Levant wormseed. Thujone, santonin. Artemisia maritima. Levant wormseed. Thujone, santonin.
  82. [82]
  83. [83]
    Thujone - an overview | ScienceDirect Topics
    The oil of the wormwood plant contains the ketoterpene thujone as a major component. Thujone acts as a convulsant. Onions, garlic, and related species are ...
  84. [84]
    [PDF] Traditional Medicine in India: Regulations and Trade
    However, herbal medicines are included in the list by 34 countries. Regulations in India. The drugs and cosmetics (d&c) act,. 19403, the drugs and cosmetics ...
  85. [85]
    A three-step enantioselective synthesis of (+)- and (−)-α-thujone
    The stereocontrolled three-step synthesis of either enantiomer of α-thujone from commercially available 3-methyl-1-butyne is described.Missing: asymmetric | Show results with:asymmetric
  86. [86]
    A six-step total synthesis of α-thujone and d 6 - RSC Publishing
    The short synthesis of α-thujone relies on the functionalization of the readily available dimethylfulvene. Furthermore, the three main metabolites of the ...
  87. [87]
    alpha-thujone, 546-80-5 - The Good Scents Company
    Alpha-thujone, CAS 546-80-5, is a fragrance agent with a thujonic, cedar-like odor, and is a colorless to pale yellow clear liquid.
  88. [88]
  89. [89]
    Insecticidal Activity against Myzus persicae of Terpinyl Acetate and ...
    Oct 19, 2022 · This study investigated the insecticidal effects of the Thuja occidentalis L. (Cupressaceae) essential oil, terpinyl acetate, and bornyl acetate ...
  90. [90]
    Chemical composition and insecticidal activity of Thuja occidentalis ...
    Aug 10, 2025 · Alfa-thujone has shown toxicity, repellent and deterrent effects on insects (e.g., Szołyga et al. 2014; Pizzolitto et al. 2015). Germacrenes are ...
  91. [91]
    Therapeutic potential of monoterpene α-thujone, the main ...
    α-thujone exerted the attenuating effect on the viability and proliferation of GBM cells when administered at the concentrations between 100 and 500 μg/ml (660 ...
  92. [92]
    Pro-apoptotic and anti-angiogenic properties of the α /β-thujone ...
    Jan 5, 2016 · In vivo assays showed that α /β-thujone promotes the regression of neoplasia and inhibits the angiogenic markers VEGF, Ang-4 and CD31 into the ...